{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:05:35Z","timestamp":1787162735434,"version":"build-2736575974"},"reference-count":125,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"University Hospital Frankfurt, Frankfurt am Main, Germany","award":["CH 806\/1-1"],"award-info":[{"award-number":["CH 806\/1-1"]}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bbadis.2018.05.017","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T13:12:36Z","timestamp":1527599556000},"page":"970-981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Animal models of autoimmune hepatitis"],"prefix":"10.1016","volume":"1865","author":[{"given":"Urs","family":"Christen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.05.017_bb0005","first-page":"1","article-title":"Breeding of a non-obese, diabetic strain of mice","volume":"29","author":"Makino","year":"1980","journal-title":"Jikken Dobutsu"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/08830185.2014.897345","article-title":"Pathogen infection and autoimmunity","volume":"33","author":"Christen","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cld.2014.09.004","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"19","author":"Czaja","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: a comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11894-011-0236-2","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"14","author":"Vierling","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0030","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bpg.2011.10.004","article-title":"Diagnostic criteria for autoimmune hepatitis","volume":"25","author":"Lohse","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0035","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0040","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1089-3261(02)00021-1","article-title":"Prevalence and epidemiology of autoimmune hepatitis","volume":"6","author":"Boberg","year":"2002","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0045","first-page":"55","article-title":"Autoimmune hepatitis\u2013approach to diagnosis","volume":"8","author":"Czaja","year":"2006","journal-title":"MedGenMed"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0050","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1155\/2013\/981086","article-title":"Challenges in the diagnosis and management of autoimmune hepatitis","volume":"27","author":"Czaja","year":"2013","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bpg.2011.08.003","article-title":"Therapy of autoimmune hepatitis","volume":"25","author":"Strassburg","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0065","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the international autoimmune hepatitis group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0070","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0080","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/1744666X.2017.1327355","article-title":"Diagnostic approach to autoimmune hepatitis","volume":"13","author":"Muratori","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00163","article-title":"Autoantibodies in autoimmune hepatitis: can epitopes tell us about the etiology of the disease?","volume":"9","author":"Christen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0095","first-page":"1206","article-title":"The validity and importance of subtypes in autoimmune hepatitis: a point of view","volume":"90","author":"Czaja","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0100","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/apt.13210","article-title":"Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype","volume":"41","author":"Muratori","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","article-title":"Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis","volume":"107","author":"Czaja","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0115","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0168-8278(96)80290-X","article-title":"Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases","volume":"25","author":"Strassburg","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0125","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0130","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","article-title":"Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II","volume":"85","author":"Zanger","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2133\/dmpk.25.84","article-title":"LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6","volume":"25","author":"Komurasaki","year":"2010","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"Zachou","year":"2004","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0145","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1568-9972(03)00036-3","article-title":"Autoimmunity and hepatitis C","volume":"2","author":"Strassburg","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0150","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2174\/138161208784746824","article-title":"HCV and autoimmunity","volume":"14","author":"Ferri","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2008-1040439","article-title":"The asialoglycoprotein receptor as target structure in autoimmune liver diseases","volume":"11","author":"Poralla","year":"1991","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0160","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"\u201cAtypical p-ANCA\u201d in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0165","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1155\/2000\/910107","article-title":"Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases","volume":"14","author":"Obermayer-Straub","year":"2000","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1081\/DMR-200028798","article-title":"Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2","volume":"37","author":"Mizutani","year":"2005","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.07.021","article-title":"Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases","volume":"450","author":"Villalta","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0185","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"Autoimmune hepatitis","volume":"63","author":"L. European Association for the Study of the EASL Clinical Practice Guidelines","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0190","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0195","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s10620-012-2151-2","article-title":"Advances in the current treatment of autoimmune hepatitis","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0200","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0205","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0210","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.1840190311","article-title":"Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis","volume":"19","author":"Doherty","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0215","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0220","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.2003.031732","article-title":"Genetics of liver disease: immunogenetics and disease pathogenesis","volume":"53","author":"Donaldson","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0225","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0230","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2004.02.023","article-title":"Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients","volume":"40","author":"Djilali-Saiah","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0235","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.005","article-title":"Cutting edge issues in autoimmune hepatitis","volume":"75","author":"Liberal","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0240","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Study of health in, genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0245","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","article-title":"Autoimmune hepatitis: clinical challenges","volume":"120","author":"Manns","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0250","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12016-013-8383-x","article-title":"Autoimmune features in metabolic liver disease: a single-center experience and review of the literature","volume":"45","author":"Tsuneyama","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0260","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease","volume":"99","author":"Adams","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0265","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00535-005-1711-z","article-title":"Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the international autoimmune hepatitis group scoring system useful?","volume":"40","author":"Yatsuji","year":"2005","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/893026","article-title":"Role of adaptive immunity in alcoholic liver disease","volume":"2012","author":"Albano","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0275","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2016.02.007","article-title":"Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model","volume":"69","author":"Muller","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0300-483X(94)03010-Y","article-title":"Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens","volume":"97","author":"Gut","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0285","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0290","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.174.9.5874","article-title":"Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid","volume":"174","author":"Amano","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0295","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","article-title":"Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease","volume":"48","author":"Wakabayashi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0300","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0092-8674(87)90507-1","article-title":"Molecular mimicry and autoimmune disease","volume":"50","author":"Oldstone","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0305","series-title":"Autoantibodies","first-page":"35","article-title":"Molecular mimiry","author":"Christen","year":"2014"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0310","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/08830185.2014.921162","article-title":"Pathogen infection as a possible cause for autoimmune hepatitis","volume":"33","author":"Christen","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0315","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.20816","article-title":"LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?","volume":"42","author":"Marceau","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0320","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0325","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0330","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaut.2011.06.005","article-title":"Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model","volume":"37","author":"Hintermann","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0335","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.pa.30.040190.001125","article-title":"Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals","volume":"30","author":"Nelson","year":"1990","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0340","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/03602539008991445","article-title":"Drug-protein conjugation and its immunological consequences","volume":"22","author":"Park","year":"1990","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0345","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0163-7258(93)90047-H","article-title":"Mechanisms of halothane toxicity: novel insights","volume":"58","author":"Gut","year":"1993","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0350","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/82161","article-title":"Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance","volume":"6","author":"Limmer","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0355","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1172\/JCI200421593","article-title":"The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity","volume":"114","author":"Bowen","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0360","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri981","article-title":"Hepatic T cells and liver tolerance","volume":"3","author":"Crispe","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0365","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.21379","article-title":"In vivo immune modulatory activity of hepatic stellate cells in mice","volume":"44","author":"Chen","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0370","first-page":"3403","article-title":"Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs","volume":"118","author":"Luth","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0375","first-page":"99","article-title":"Experimental chronic active hepatitis in rabbits following immunization with human liver proteins","volume":"11","author":"Meyer zum Buschenfelde","year":"1972","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0380","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0016-5085(83)90085-9","article-title":"Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae","volume":"84","author":"Kuriki","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0385","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840110106","article-title":"Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity","volume":"11","author":"Lohse","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0390","first-page":"105","article-title":"Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice","volume":"67","author":"Watanabe","year":"1987","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0395","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.184.2.387","article-title":"Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation","volume":"184","author":"Asano","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0400","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/hep.510270611","article-title":"Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression","volume":"27","author":"Lohse","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0405","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.3748\/wjg.v13.i31.4249","article-title":"Inhibition of p38 mitogen-activated protein kinase attenuates experimental autoimmune hepatitis: involvement of nuclear factor kappa B","volume":"13","author":"Ma","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0410","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.28001","article-title":"B cells expressing CD11b effectively inhibit CD4+ T-cell responses and ameliorate experimental autoimmune hepatitis in mice","volume":"62","author":"Liu","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0415","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0420","first-page":"176","article-title":"Experimental hepatitis and role of cytokines","volume":"60","author":"Tiegs","year":"1997","journal-title":"Acta Gastroenterol. Belg."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0425","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/gast.1996.v111.pm8690213","article-title":"Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A","volume":"111","author":"Kusters","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0430","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/excr.1996.0351","article-title":"T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release","volume":"229","author":"Gantner","year":"1996","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0435","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1423-0127-16-10","article-title":"Lectin of concanavalin A as an anti-hepatoma therapeutic agent","volume":"16","author":"Lei","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0440","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1073\/pnas.040566697","article-title":"Critical contribution of liver natural killer T cells to a murine model of hepatitis","volume":"97","author":"Takeda","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0445","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.biopha.2017.07.015","article-title":"The therapeutic effects of Yongdamsagan-tang on autoimmune hepatitis models","volume":"94","author":"Park","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0450","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/liv.12266","article-title":"Herb-induced autoimmune-like hepatitis in C57BL\/6J mice","volume":"34","author":"Wang","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0455","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0460","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.gastro.2013.03.011","article-title":"Splenectomy prolongs the effects of corticosteroids in mouse models of autoimmune hepatitis","volume":"145","author":"Maruoka","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0465","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.27087","article-title":"Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice","volume":"60","author":"Ikeda","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066604","article-title":"Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases","volume":"8","author":"Qi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0475","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1172\/JCI28349","article-title":"Immunoprivileged status of the liver is controlled by toll-like receptor 3 signaling","volume":"116","author":"Lang","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0480","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1053\/gast.2001.27103","article-title":"Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"121","author":"Obermayer-Straub","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0485","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/hep.27639","article-title":"Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigens","volume":"61","author":"Hardtke-Wolenski","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0490","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1172\/JCI65414","article-title":"Medullary thymic epithelial cell depletion leads to autoimmune hepatitis","volume":"123","author":"Bonito","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0495","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3390\/ijms16011980","article-title":"Medullary thymic epithelial cells and central tolerance in autoimmune hepatitis development: novel perspective from a new mouse model","volume":"16","author":"Alexandropoulos","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0500","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2009.08.001","article-title":"Viral triggers for autoimmunity: is the \u2018glass of molecular mimicry\u2019 half full or half empty?","volume":"34","author":"Christen","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0505","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.4049\/jimmunol.152.7.3245","article-title":"Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo","volume":"152","author":"Ando","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0510","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1691527","article-title":"Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice","volume":"248","author":"Moriyama","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0515","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(91)90165-U","article-title":"Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response","volume":"65","author":"Oldstone","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0520","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/cmi.2010.71","article-title":"Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?","volume":"8","author":"Christen","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0525","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.8303275","article-title":"Levels of peripheral T cell tolerance induced by different doses of tolerogen","volume":"263","author":"Ferber","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0530","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2395::AID-IMMU2395>3.0.CO;2-D","article-title":"Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment","volume":"28","author":"Limmer","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0535","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1002\/1521-4141(200212)32:12<3628::AID-IMMU3628>3.0.CO;2-E","article-title":"CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes","volume":"32","author":"Sacher","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0540","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/eji.1830250721","article-title":"Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver","volume":"25","author":"Bertolino","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0545","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/intimm\/11.8.1225","article-title":"Death by neglect as a deletional mechanism of peripheral tolerance","volume":"11","author":"Bertolino","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0550","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jhep.2006.08.022","article-title":"Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis","volume":"46","author":"Warren","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0555","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/hep.21796","article-title":"Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis","volume":"46","author":"Derkow","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0560","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.4049\/jimmunol.165.5.2415","article-title":"Break of T cell ignorance to a viral antigen in the liver induces hepatitis","volume":"165","author":"Voehringer","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0565","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.164.4.1075","article-title":"T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?","volume":"164","author":"Zinkernagel","year":"1986","journal-title":"J. Exp. Med."},{"issue":"986","key":"10.1016\/j.bbadis.2018.05.017_bb0570","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2010.05.075","article-title":"Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis","volume":"139","author":"Zierden","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0575","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000481341","article-title":"Hepatic T cell tolerance induction in an inflammatory environment","volume":"36","author":"Dywicki","year":"2018","journal-title":"Dig. Dis."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0580","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.4049\/jimmunol.169.9.4889","article-title":"DNA vaccination breaks tolerance for a neo-self antigen in liver: a transgenic murine model of autoimmune hepatitis","volume":"169","author":"Djilali-Saiah","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0585","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.20109","article-title":"A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens","volume":"39","author":"Lapierre","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0590","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clim.2005.08.010","article-title":"Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12","volume":"117","author":"Tamaki","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0595","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.4049\/jimmunol.1600228","article-title":"Transient expression of transgenic IL-12 in mouse liver triggers unremitting inflammation mimicking human autoimmune hepatitis","volume":"197","author":"Gil-Farina","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0600","first-page":"1","article-title":"The CYP2D6 animal model: how to induce autoimmune hepatitis in mice","volume":"60","author":"Hintermann","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0605","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2012.11.001","article-title":"Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis","author":"Ehser","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0615","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2013.05.001","article-title":"Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6","volume":"44","author":"Hintermann","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbadis.2018.05.017_bb0620","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/hep.26380","article-title":"Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells","volume":"58","author":"Hardtke-Wolenski","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.05.017_bb0625","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.intimp.2011.05.020","article-title":"Autoimmune hepatitis-like disease in C57BL\/6 mice infected with mouse hepatitis virus A59","volume":"11","author":"Aparicio","year":"2011","journal-title":"Int. Immunopharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391830187X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391830187X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:49:28Z","timestamp":1760417368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544391830187X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":125,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S092544391830187X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.05.017","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models of autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}